Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | -8.43% | -36.17% | -55.88% |
Sales 2024 * | 14.8M 1.16B | Sales 2025 * | 19.28M 1.51B | Capitalization | 3.96M 309M |
---|---|---|---|---|---|
Net income 2024 * | -3M -234M | Net income 2025 * | - 0 | EV / Sales 2024 * | 0.27 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.21 x |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
3.6
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 2.86% |
Latest transcript on NovaBay Pharmaceuticals
1 day | -8.43% | ||
1 week | -36.17% | ||
Current month | -8.43% | ||
1 month | -5.16% | ||
3 months | -40.04% | ||
6 months | -68.97% | ||
Current year | -55.88% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 31/01/13 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 30/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 30/04/02 |
Yen You Zheng
BRD | Director/Board Member | 67 | 10/09/19 |
Bob Wu
BRD | Director/Board Member | 49 | 25/01/16 |
Date | Price | Change | Volume |
---|---|---|---|
03/06/24 | 3.15 | -8.43% | 170 407 |
31/05/24 | 3.44 | -5.68% | 314,914 |
30/05/24 | 3.647 | -36.11% | 572,721 |
29/05/24 | 5.708 | +15.67% | 1,408,562 |
28/05/24 | 4.935 | +6.98% | 267,863 |
Delayed Quote Nyse, June 03, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.88% | 3.96M | |
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |
- Stock Market
- Equities
- NBY Stock